JW Pharmaceutical Corporation develops, manufactures, and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cardiovascular, gastrointestinal, urinary, oral hypoglycemic, antibiotics, anti-fungal, Ob and Gy, renal, CNS, anti-anemic, respiratory, rheumatic arthritis, anticancer, anesthetic, antidotes, amino acids, TPN, and others. The company was founded in 1945 and is headquartered in Seoul, South Korea.

Sung-Yeol  Lee

Chief Executive Officer, Head of Product Development & Management and Director

Kim Yong  Kwan

Development Head & Internal Director

Mr. Young-Sub  Shin

Chief Executive Officer, Head of Sales & Marketing and Inside Director

Jae-Kwang  Jeon

Head Managing Director and Head of Public Relation

Mr. Hyun-seok  Han

Head of Product Plant

Pavadinimas	Rinkos kapitalizacija
China Medical System Holdings Limited	0M
TILT Holdings Inc.	0M
ZhuZhou QianJin Pharmaceutical Co.,Ltd	0M
Wockhardt Limited	0M
Chong Kun Dang Pharmaceutical Corp.	0.1M
Eris Lifesciences Limited	0M
Shenzhen Kangtai Biological Products Co., Ltd.	0M
Takeda Pharmaceutical Company Limited	0M
Medical Developments International Limited	0M
Alembic Pharmaceuticals Limited	0M
Hanmi Pharm. Co., Ltd.	0.3M

JW Pharmaceutical Corporation

JW Pharmaceutical Corporation Konkurentų sąrašas

Pagrindiniai konkurentai